EKF Diagnostics Holdings PLC (LSE:EKF) - Share price


Stock Report

EKF Diagnostics Holdings PLC EKF

Last Price
GBX75.00

Day Change
0.00|0.00%

As of 26/11/2021
16:35:09 GMT | GBX
Minimum 15 Minutes Delay.

Last Close75.00p
Day Range73.20 - 77.00
Mkt Cap347.90Mil
52-Wk Range59.00 - 95.00
Yield %1.47
ISINGB0031509804
Volume218,504
P/E21.23
P/S0.05
P/CF0.25

Share Price

Total Returns 26/11/2021

 Chg (%)  
More ...
EKF Diagnostics Holdings PLC-5.58 
FTSE 100 TR GBP-2.91
 
Financials
201820192020
More ...
Income Statement
Turnover42.5444.9265.26
Operating Profit12.205.7816.90
Net Profit10.303.9311.39
Reported EPS2.190.802.42
Balance Sheet
Current Assets23.8326.2443.95
Non Current Assets57.5560.8857.31
Total Assets81.3887.13101.27
Current Liabilities13.6012.1419.42
Total Liabilities17.4815.9523.07
Total Equity63.9071.1778.20
Cash Flow
Operating Cash Flow9.836.5020.75
Net Change in Cash1.902.079.94

Regulatory News

DateAuthor Headline
24/01/2013Chris Menon 5 Small-caps Worth a Closer Look
For patient investors willing to do their own research there are a lot of opportunities among small-caps
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
08/11/2021SaleMr. Julian Baines80.76250,000201,900.00
01/10/2021SaleMr. Christopher Harwood Bernard Mills84.00637,500535,500.00
01/10/2021SaleMr. Christopher Harwood Bernard Mills84.00637,500535,500.00
30/04/2021SaleMr. Adam Reynolds73.05500,000365,250.00

Company Profile

EKF Diagnostics Holdings PLC is engaged in the field of medical diagnostics. The company core business is point-of-care testing and to manufacture reagents for use in central laboratories. It caters to companies focused on areas such as diabetes, blood banking, and sports medicine. The company derives most of its income from its sales in the United States. Its other markets include Germany, Poland, and Russia.

Sector

Medical Devices

Index

FTSE AIM 100 , FTSE AIM All-Share

Next Event 30/03/2022

Final Results
Ratios
Comp
More ...
PER (E)22.95
Div Yld (E)1.23
PEG (E)0.00
ROCE18.85
Op Mrgn0.26
EPS Grwth2.03
Dividends
PreviousLatest
More ...
Record Date06/11/2005/11/21
Ex-Div05/11/2004/11/21
Paid01/12/2001/12/21
Amnt1.001.10
Directors
More ...
Non-Executive Director, ChairmanMr. Christopher Harwood Bernard Mills
Non-Executive Director, Deputy ChairmanMr. Julian Baines
Executive Director, Finance Director and Chief Operating OfficerMr. Richard Anthony Evans
Company SecretaryMr. Salim Hamir
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2021 Morningstar. All rights reserved.